Ciprofloxacin susceptibility reduction of Salmonella strains isolated from outbreaks

Brazilian Journal of Microbiology

Volumn 41, Issue 2, 2010, Pages 497-500

  Souza, Roberta B ^a   Ferrari, Rafaela G ^a   Magnani, Marciane ^a   Kottwitz, Luciana B M ^a   Alcocer, Iliana ^b   Tognim, Maria Cristina B ^c   Oliveira, Tereza C R M ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DEL ECUADOR   (Ecuador)

^c STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Antimicrobial resistance; Fluoroquinolones; Minimal inhibitory concentration (MIC); Quinolones

Indexed keywords

SALMONELLA;

EID: 77951012061     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/S1517-83822010000200033     Document Type: Article

References (22)

1. Angulo, F.; Johnson, K.; Tauxe, R.; Cohen, M. (2000). Significance and sources of antimicrobial-resistant nontyphoidal Salmonella infections in the United States. Microb. Drug Resist., 1, 77-83.
2. Biedenbach, D.J.; Toleman, M.; Walsh, T.R.; Jones, R.N. (2006). Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporin and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Diagn. Microbiol. Infect. Dis., 54, 13-21.
3. Butaye P.; Michael, G.B.; Schwarz, S.; Barrett, T.J.; Brisabois, A.; White, D.G. (2006). The clonal spread of multidrug-resistant non-typhi Salmonella serotypes. Microbes Infect., 8, 1891-1897.
4. Cebrian, L.; Sirvent, E.R.; Díaz, J.C. (2003). Characterization of Salmonella spp. mutants produced by exposure to various fluoroquinolones. Int. J. Antimicrob. Agents, 22, 134-139.
5. Clinical and Laboratory Standards Institute (2006). Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S16. CLSI, Wayne, PA, USA.
6. Duarte, D.A.M., Ribeiro, A.R., Vasconcelos, A.M.M.; Santos, S.B.; Silva, J.V.D.; Patrícia Andrade, P.L.A.; Falcão L.S.P.C.A. (2009). Occurrence of Salmonella spp. in broiler chicken carcasses and their susceptibility to antimicrobial agents. Braz. J. Microbiol., 40: 569-573.
7. Eaves, D.J.; Randall, L.; Gray, D.T.; Buckley, A.; Woodward, M.J.; White, A.P.; Piddock, L.J.V. (2004). Prevalence of Mutations within the Quinolone Resistance-Determining Region of gyrA, gyrB, parC e parE and Association with Antibiotic Resistance in Quinolone-Resistant Salmonella enterica. Antimicrob. Agents Chemother., 48 (10), 4012-4015.
8. Escribano, I.; Rodríguez, J. C.; Cebrian, L.; Royo, G. (2004). The importance of active efflux systems in the quinolone resistance of clinical isolates of Salmonella spp. Int. J. Antimicrob. Agents, 24, 428-432.
9. Giraud, E.; Baucheron, S.; Cloeckaert, A. (2006). Resistance to fluoroquinolones in Salmonella: emerging mechanisms and resistance prevention strategies. Microb. Infect., 8, 1937-1944.
10. Hakanen, A.; Kotilainen, P.; Huovinen, P. (2001). Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerging Infect. Dis., 7, 996-1003.
11. Hooper, D.C. (2001) Emerging Mechanism of Fluoroquinolone Resistance. Emerging Infect. Dis., 7, 337-341.
12. Hopkins, K.L.; Davies, R.H.; Threlfall, E.J. (2005). Mechanisms of quinolone resistance in Escherichia coli and Salmonella: Recent developments. Int. J. Antimicrob. Agents, 25, 358-73.
13. Murray, A.; Coia, J.E.; Mather, H.; Brown, D.J. (2005). Ciprofloxacin resistance in non-typhoidal Salmonella serotypes in Scotland, 1993-2003. J. Antimicrob. Chemother., 56, 110-114.
14. Piddock, L.J.V. (1998). Fluoroquinolone resistance: Overuse of fluoroquinolones in human and veterinary medicine can breed resistance. BMJ, 317, 1029-1030.
15. Piddock, L.V.J. (2002). Fluoroquinolone resistance in Salmonella serovars isolated from humans and food animals. FEMS Microbiol. Rew., 26, 3-16.
16. Reller, M.; McClellan, J.; Joyce, K.; Polyak, C.; Mintz, E.; Angulo, F., and NARMS WORKING GROUP (2002). Emerging resistance to quinolones among Salmonella Typhi isolates in the United States, 1999-2001. Infect. Dis. Soc. Am.
17. Ribeiro, A.R.; Kellermann, A.; Santos, L.R.; Fittél, A. P.; Nascimento, V.P. (2007). Salmonella spp. in Raw Broiler Parts: Occurrence, Antimicrobial Resistance Profile and Phage Typing of The Salmonella Enteritidis Isolates. Braz. J. Microbiol., 38, 296-299.
18. San-Martín, B.; Lapierre, L.; Toro, C.; Bravo, V.; Cornejo, J.; Hormazabal, J. C.; Borie C. (2005). Isolation and molecular characterization of quinolone resistant Salmonella spp. from poultry farms. Vet. Microbiol., 110, 239-244.
19. Soto, S.M.; Ruíz, J.; Mendoza, M.C.; Vila, J. (2003). In vitro fluoroquinolone-resistant mutants of Salmonella enterica serotype Enteritidis: analysis of mechanisms involved in resistance. Int. J. Antimicrob. Agents, 22, 537-540.
20. Threlfall, E.J. (2002) Antimicrobial drug resistance in Salmonella: problems and perspectives in food- and water-borne infections. FEMS Microbiol. Rev., 26, 141-148.
21. Threlfall, E.J.; Fisher, I.S.T.; Berghold, C. (2003). Antimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: results of international multicentre surveillance. Eurosurveillance - European Communicable Disease Bolletin: Salmonella, 82(2):41-45.
22. WHO Global Salm-Surv. (2006) Progress report (2000-2005): building capacity for laboratory-based foodborne disease surveillance and outbreak detection and response.